The price of Hims & Hers Health Inc (NYSE:HIMS) shares last traded on Wall Street fell -34.63%% to $41.98.
HIMS stock price is now -11.54% away from the 50-day moving average and 25.46% away from the 200-day moving average. The market capitalization of the company currently stands at $9.40B.
On June 04, 2025, Needham reiterated its ‘Buy’ rating on the stock by increasing its target price from $61 to quote $65, while ‘TD Cowen’ rates the stock as ‘Hold’
In other news, Oluyemi Okupe, Officer bought 69,431 shares of the company’s stock on Jun 23 ’25. The stock was bought for $2,914,713 at an average price of $41.98. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 17 ’25, Chief Commercial Officer Chi Michael sold 17,102 shares of the business’s stock. A total of $1,021,844 was realized by selling the stock at an average price of $59.75. This leaves the insider owning 278,654 shares of the company worth $11.7 million. A total of 14.88% of the company’s stock is owned by insiders.
During the past 12 months, Hims & Hers Health Inc has had a low of $13.47 and a high of $72.98. As of last week, the company has a debt-to-equity ratio of 0.12, a current ratio of 1.59, and a quick ratio of 1.32.
The net profit margin was 9.21% and return on equity was 36.79% for HIMS. The company reported revenue of $586.01 million for the quarter, compared to $278.17 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 110.67 percent.
